Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Efficacy of CCR4 antagonist from AstraZeneca tested in canine model of atopic dermatitis

March 8, 2016

Lilly presents efficacy and safety analyses of ixekizumab for moderate-to-severe psoriasis

March 8, 2016

Total levels of IgE are elevated in patients with hidradenitis suppurativa

March 7, 2016

BioPharmX initiates phase IIa study of BPX-01 for acne

March 7, 2016

EMA CHMP issues positive opinion for ixekizumab for plaque psoriasis

Feb. 29, 2016

Novan initiates phase III program of SB-204 for acne

Feb. 24, 2016

FDA approves revised product label for Epicel

Feb. 23, 2016

Knight Therapeutics supports Medimetriks' acquisition of OPA-15406

Feb. 18, 2016

Filaggrin inhibits formation of lipid antigens in human skin

Feb. 15, 2016

Otsuka licenses U.S. rights for atopic dermatitis treatment OPA-15406 to Medimetriks

Feb. 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...